Literature DB >> 23532779

Coronary stents: historical development, current status and future directions.

Javaid Iqbal1, Julian Gunn, Patrick W Serruys.   

Abstract

INTRODUCTION: Coronary angioplasty with stenting has revolutionized the treatment of coronary artery disease. This article describes the history of coronary angioplasty and stenting, reviews the contemporary stents and recommendations and highlights the on-going work and potential future directions. SOURCES OF DATA: This review examined the data on coronary stents available in PubMed. AREAS OF AGREEMENT: Coronary artery stenting is the treatment of choice for patients requiring coronary angioplasty. Stents, and particularly drug-eluting stents, reduce the risk of restenosis, but may be associated with the hazard of late stent thrombosis. Dual anti-platelet treatment is recommended for patients receiving coronary stents. AREAS OF CONTROVERSY: The selection of stents for various lesions and patients and the duration of anti-platelet therapy remain debated areas. AREAS TIMELY FOR DEVELOPING RESEARCH: There are on-going preclinical and clinical studies to develop better stent platforms, more biocompatible polymers, novel anti-proliferative and anti-platelet drugs, pro-healing stents and bioresorbable scaffolds.

Entities:  

Keywords:  angioplasty; bare metal stents; bioresorbable vascular scaffold; drug-eluting stents; stents

Mesh:

Substances:

Year:  2013        PMID: 23532779     DOI: 10.1093/bmb/ldt009

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  60 in total

Review 1.  Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease.

Authors:  Piroze M Davierwala; Freidrich W Mohr
Journal:  Curr Atheroscler Rep       Date:  2014-12       Impact factor: 5.113

2.  Effects of endothelium, stent design and deployment on the nitric oxide transport in stented artery: a potential role in stent restenosis and thrombosis.

Authors:  Xiao Liu; Min Wang; Nan Zhang; Zhanming Fan; Yubo Fan; Xiaoyan Deng
Journal:  Med Biol Eng Comput       Date:  2015-02-26       Impact factor: 2.602

3.  Semi-intrusive multiscale metamodelling uncertainty quantification with application to a model of in-stent restenosis.

Authors:  A Nikishova; L Veen; P Zun; A G Hoekstra
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2019-04-08       Impact factor: 4.226

4.  The stentable in vitro artery: an instrumented platform for endovascular device development and optimization.

Authors:  Elizabeth E Antoine; François P Cornat; Abdul I Barakat
Journal:  J R Soc Interface       Date:  2016-12       Impact factor: 4.118

Review 5.  Bioresorbable Scaffolds: Current Evidences in the Treatment of Coronary Artery Disease.

Authors:  Bhargav Dave
Journal:  J Clin Diagn Res       Date:  2016-10-01

Review 6.  Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases.

Authors:  Mohan Satish; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2019-01-09

Review 7.  Basic Concepts and Clinical Outcomes of Drug-Eluting Balloons for Treatment of Coronary Artery Disease: An Overview.

Authors:  C D Ramakrishna; Bhargav A Dave; Pankaj S Kothavade; Kajal J Joshi; Ashok S Thakkar
Journal:  J Clin Diagn Res       Date:  2017-06-01

8.  Murine model of femoral artery wire injury with implantation of a perivascular drug delivery patch.

Authors:  Victoria Le; Collin G Johnson; Jonathan D Lee; Aaron B Baker
Journal:  J Vis Exp       Date:  2015-02-10       Impact factor: 1.355

9.  Stability and bioactivity of pepCD47 attachment on stainless steel surfaces.

Authors:  Vaishali V Inamdar; Emmett Fitzpatrick; Ivan Alferiev; Chandrasekaran Nagaswami; Lynn A Spruce; Hossein Fazelinia; George Bratinov; Steven H Seeholzer; Robert J Levy; Ilia Fishbein; Stanley J Stachelek
Journal:  Acta Biomater       Date:  2020-01-11       Impact factor: 8.947

Review 10.  Optimal revascularization for complex coronary artery disease.

Authors:  Javaid Iqbal; Patrick W Serruys; David P Taggart
Journal:  Nat Rev Cardiol       Date:  2013-09-17       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.